Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer

EMBO Mol Med. 2016 Apr 1;8(4):388-406. doi: 10.15252/emmm.201606273.

Abstract

Pregnancy is associated with a transient increase in risk for breast cancer. However, the mechanism underlying pregnancy-associated breast cancer (PABC) is poorly understood. Here, we identify the protease pappalysin-1 (PAPP-A) as a pregnancy-dependent oncogene. Transgenic expression of PAPP-A in the mouse mammary gland during pregnancy and involution promotes the deposition of collagen. We demonstrate that collagen facilitates the proteolysis of IGFBP-4 and IGFBP-5 by PAPP-A, resulting in increased proliferative signaling during gestation and a delayed involution. However, while studying the effect of lactation, we found that although PAPP-A transgenic mice lactating for an extended period of time do not develop mammary tumors, those that lactate for a short period develop mammary tumors characterized by a tumor-associated collagen signature (TACS-3). Mechanistically, we found that the protective effect of lactation is associated with the expression of inhibitors of PAPP-A, STC1, and STC2. Collectively, these results identify PAPP-A as a pregnancy-dependent oncogene while also showing that extended lactation is protective against PAPP-A-mediated carcinogenesis. Our results offer the first mechanism that explains the link between breast cancer, pregnancy, and breastfeeding.

Keywords: IGF‐binding protein 4 and 5; breastfeeding; insulin‐like growth (IGF) factor signaling; involution.

MeSH terms

  • Animals
  • Breast Neoplasms / physiopathology*
  • Female
  • Humans
  • Lactation*
  • Mice
  • Mice, Transgenic
  • Pregnancy
  • Pregnancy Complications / physiopathology*
  • Pregnancy-Associated Plasma Protein-A / metabolism*

Substances

  • Pregnancy-Associated Plasma Protein-A
  • PAPPA protein, human